| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics, Inc. | Director | Common Stock | 134K | $94.9K | $0.71 | Aug 16, 2024 | Direct |
| Cyclo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.6K | Jun 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics, Inc. | Aug 16, 2024 | 1 | $0 | 4 | Aug 20, 2024 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Jun 3, 2024 | 2 | $0 | 4 | Jun 5, 2024 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Nov 28, 2023 | 1 | $0 | 4 | Nov 30, 2023 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Aug 18, 2023 | 1 | $0 | 4 | Aug 22, 2023 | Director |
| CYTH | Cyclo Therapeutics, Inc. | May 17, 2023 | 1 | $0 | 4 | May 18, 2023 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Mar 7, 2023 | 1 | $0 | 4 | Mar 9, 2023 | Director |
| CYTH | Cyclo Therapeutics, Inc. | Aug 27, 2021 | 1 | $0 | 4 | Aug 31, 2021 | Director |